Inovio (NASDAQ: INO) CEO receives new RSUs and options as shares withheld for taxes
Rhea-AI Filing Summary
INOVIO PHARMACEUTICALS, INC. reported routine equity compensation and related tax withholding transactions for CEO Jacqueline Elizabeth Shea. On May 20, 2026, 28,296 restricted stock units vested and were settled into common shares, with 12,306 shares withheld at $1.23 per share to cover tax obligations. Shea exercised a derivative award for 28,296 shares of common stock and, following this exercise, held 123,327 common shares directly, while after the tax withholding entry she held 111,021 shares directly. She also received new grants of 100,240 restricted stock units and 123,760 stock options with a $1.73 exercise price, vesting in equal annual installments from February 26, 2027 through February 26, 2029.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 28,296 | $0.00 | $0.00 |
| Grant/Award | Common Stock Option | 123,760 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 100,240 | $0.00 | $0.00 |
| Exercise | Common Stock | 28,296 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 12,306 | $1.23 | $15K |
Footnotes (6)
- F1. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- F2. The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
- F3. The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026.
- F4. The vesting schedule for the options granted on May 20, 2026 was as follows: 41,254 shares will vest on February 26, 2027; 41,253 shares will vest on February 26, 2028; 41,253 shares will vest on February 26, 2029.
- F5. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 33,414 shares will vest on February 26, 2027; 33,413 shares will vest on February 26, 2028; and 33,413 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- F6. The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026.
Key Figures
Key Terms
Restricted Stock Unit financial
tax withholding obligations financial
stock option grant financial
Omnibus Incentive Plan financial
Exercise or conversion of derivative security financial
AI-generated analysis. How Rhea-AI works. Not financial advice.